Vitality Watch

Dossier clinicaltrials observational 22-jun-2026
Human cohort, case-control, or epidemiological association

Olfactory Dysfunction in Aging Adults

Key claim: A prospective longitudinal cohort of adults aged 50+ will define anatomic phenotypes of olfactory dysfunction and link them to cognition, biomarkers, imaging, quality of life, and change over time.

Abstract

This prospective longitudinal cohort study will enroll adults aged 50 years and older to characterize olfactory dysfunction in aging. Participants will undergo comprehensive olfactory testing, cognitive assessment, biomarker collection, and imaging to identify clinically relevant phenotypes based on anatomic site of dysfunction. The study will also evaluate the impact of olfactory dysfunction on quality of life and identify baseline factors associated with changes in olfactory function over time.

Why this matters

A prospective longitudinal cohort of adults aged 50+ will define anatomic phenotypes of olfactory dysfunction and link them to cognition, biomarkers, imaging, quality of life, and change over time.

Source

Link

Briefing card

Olfactory Dysfunction in Aging Adults
Stage: observational · clinicaltrials · 22-jun-2026

A prospective longitudinal cohort of adults aged 50+ will define anatomic phenotypes of olfactory dysfunction and link them to cognition, biomarkers, imaging, quality of life, and change over time.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07660887

build build 880 · 2bcef25 · 2026-11-18